4//SEC Filing
Matushansky Igor 4
Accession 0001790340-25-000049
CIK 0001790340other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:12 PM ET
Size
5.5 KB
Accession
0001790340-25-000049
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Matushansky Igor
Chief Medical Officer
Transactions
- Award
Stock Option
2025-03-21+118,000→ 118,000 totalExercise: $1.80Exp: 2035-03-21→ Class A Common Stock (118,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 17, 2026 and then in equal monthly installments over the subsequent three years, subject to the reporting person's continued employment through each applicable vesting date.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001768208
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 4:12 PM ET
- Size
- 5.5 KB